Merz buys out BioForm Medical, makers of Radiesse
Wow, that was fast. One prediction - market consolidation - is already coming true.
CnnMoney.com reports that Merz Pharma Group ("Merz"), a privately-held company based in Frankfurt, Germany, is going forward with a buy-out of BioForm Medical, in a $253 million stock deal.
BioForm Medical is the maker of RADIESSE dermal filler. Merz has several fillers used in Europe - but not in the U.S., and is about to come out with a Botox-competitor, named Xeomin.
For patients though, not to worry: Radiesse will still remain in the U.S. marketplace.
CnnMoney.com reports that Merz Pharma Group ("Merz"), a privately-held company based in Frankfurt, Germany, is going forward with a buy-out of BioForm Medical, in a $253 million stock deal.
BioForm Medical is the maker of RADIESSE dermal filler. Merz has several fillers used in Europe - but not in the U.S., and is about to come out with a Botox-competitor, named Xeomin.
For patients though, not to worry: Radiesse will still remain in the U.S. marketplace.
Labels: Bioform, buyout, market consolidation, Merz, predictions, Radiesse
posted by Thomas Fiala, MD, FACS, FRCSC 7:59 AM
Copyright © 2009 Plastic Surgery in Florida. All Rights Reserved.
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home